Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 275-281

  Deleau, Céline ^a   Buecher, Bruno ^a   Rousseau, Caroline ^c   Kraeber Bodéré, Françoise ^c   Flamant, Mathurin ^a   Des Varannes, Stanislas Bruley ^a   Frampas, Eric ^b   Galmiche, Jean Paul ^a   Matysiak Budnik, Tamara ^a  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Team 12   (France)

Author keywords

cancer recurrence; colorectal cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 79951900965     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328343eaa0     Document Type: Article

References (25)

1. Boyle P, Leon ME. Epidemiology of colorectal cancer. Br Med Bull 2002; 64:1-25. (Pubitemid 35238576)
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18:581-592.
3. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13:668-676.
4. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94:982-999.
5. Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 2009; 96:1058-1065.
6. Zervos EE, Badgwell BD, Burak WE Jr, Arnold MW, Martin EW. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery 2001; 130:636-643.
7. Zhang C, Chen Y, Xue H, Zheng P, Tong J, Liu J, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009; 124:167-173.
8. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41:1177-1189. (Pubitemid 30464000)
9. Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Loyynska R, Trskova K, et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2006; 33:779-784. (Pubitemid 43979685)
10. 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med 2008; 49:354-361.
11. 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 2008; 98:875-880.
12. Kitajima K, Murakami K, Yamasaki E, Dommeki Y, Tsubaki M, Sunagawa M, et al. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET/non-contrast- enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging 2009; 36:1388-1396.
13. Watson AJ, Lolohea S, Robertson GM, Frizelle FA. The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 2007; 50:102-114.
14. Grassetto G, Fornasiero A, Bonciarelli G, Banti E, Rampin L, Marzola MC, et al. Additional value of FDG-PET/CT in management of 'solitary' liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol 2010; 12:139-144.
15. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007; 34:1583-1593. (Pubitemid 47476915)
16. Herbertson RA, Scarsbrook AF, Lee ST, Tebbutt N, Scott AM. Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol 2009; 64:225-237.
17. Bamba Y, Itabashi M, Kameoka S. Management of local recurrence of colorectal cancer: the role of PET/CT. Abdom Imaging. 2010. [Epub ahead of print]
18. Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT. Eur J Radiol 2010; 73:324-328.
19. Selzner M, Hany TF, Wildbrett P, Mc Cormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-1034.
20. 18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. J Am Coll Surg 2008; 206:857-868.
21. King J, Glenn D, Clark W, Zhao J, Steinke K, Clingan P, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004; 91:217-223. (Pubitemid 38233968)
22. Lonneux M, Reffad AM, Detry R, Kartheuser A, Gigot JF, Pauwels S. FDGPET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2002; 29:915-921. (Pubitemid 34671297)
23. Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG PET in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43:759-767.
24. Kantorová I, Lipská L, Bêlohlávek O, Visokai V, Trubac M, Schneiderova M. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003; 44:1784-1788.
25. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227:319-323. (Pubitemid 28131010)